Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy
Mediators of Inflammation, ISSN: 0962-9351, Vol: 2012, Page: 629452
2012
- 73Citations
- 21Usage
- 150Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations73
- Citation Indexes73
- 73
- CrossRef36
- Usage21
- Abstract Views21
- Captures150
- Readers150
- 91
- 58
- Mentions1
- News Mentions1
- 1
Most Recent News
Anatomical and Functional Outcomes of Use of Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy
2023 OCT 04 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Staff editors report on the newly launched clinical trial,
Review Description
The global prevalence of diabetes is estimated to be 336 million people, with diabetic complications contributing to significant worldwide morbidity and mortality. Diabetic retinopathy results from cumulative microvascular damage to the retina and inflammation is recognized as a critical driver of this disease process. This paper outlines the pathophysiology leading to proliferative diabetic retinopathy and highlights many of the inflammatory, angiogenic, and cytokine mediators implicated in the development and progression of this disease. We focus a detailed discussion on the current targeted therapeutic interventions used to treat diabetic retinopathy. © 2012 Daniel Gologorsky et al.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84867830181&origin=inward; http://dx.doi.org/10.1155/2012/629452; http://www.ncbi.nlm.nih.gov/pubmed/23028203; http://www.hindawi.com/journals/mi/2012/629452/; https://www.airitilibrary.com/Article/Detail/P20160527003-201212-201703010014-201703010014-277-286-127; https://dx.doi.org/10.1155/2012/629452; https://www.hindawi.com/journals/mi/2012/629452/; https://downloads.hindawi.com/journals/mi/2012/629452.pdf
Hindawi Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know